[Clinical use of the dexamethasone suppression test].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000928:Antidepressive Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000503:physiopathology; D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000401:mortality / Q000503:physiopathology* / Q000628:therapy; D003907:Dexamethasone; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011613:Psychotherapy; D012306:Risk; D013405:Suicide / Q000453:epidemiology; D013972:Thyrotropin / Q000097:blood; D013973:Thyrotropin-Releasing Hormone
D000928:Antidepressive Agents; D013973:Thyrotropin-Releasing Hormone; D003907:Dexamethasone; D013972:Thyrotropin; D006854:Hydrocortisone
Impiego clinico del test di soppressione al desametazone.